Advertisement

Topics

Orgenesis subsidiary MaSTherCell Global to build new facility in Belgium for cell and gene therapy manufacturing

06:51 EDT 25 Mar 2019 | Proactive Investors

The new 61,354 square foot production facility in Gosselies Biopark, in Belgium is expected to triple the company’s European capacity

Original Article: Orgenesis subsidiary MaSTherCell Global to build new facility in Belgium for cell and gene therapy manufacturing

NEXT ARTICLE

More From BioPortfolio on "Orgenesis subsidiary MaSTherCell Global to build new facility in Belgium for cell and gene therapy manufacturing"

Advertisement
Quick Search
Advertisement
Advertisement